FEAM:NASDAQ5E Advanced Materials, Inc. Analysis
Data as of 2026-06-17 - not real-time
$1.62
Latest Price
8/10Risk
Risk Level: High
Executive Summary
FEAM is trading at $1.62, well below its 20‑day SMA of $1.79 and the 50‑day SMA of $1.72, indicating short‑term weakness, while the 200‑day SMA sits near $3.00, underscoring a long‑term downtrend. The RSI of 44 suggests the stock is neither overbought nor oversold, and the MACD histogram remains negative with a bearish signal line, reinforcing downside momentum. Beta of 1.95 and a 30‑day volatility of over 120% point to extreme price swings, amplified by a market‑cap of roughly $67 million and modest average volumes, creating notable liquidity risk. Despite these technical headwinds, the upside/downside percentage of 193% and a consensus target price of $4.75 imply substantial upside potential if the company’s exploration milestones—highlighted in recent news about a positive lithium PEA and progress at the Fort Cady project—materialize. The balance sheet shows $25.4 million in cash against minimal debt, but operating cash flow and free cash flow are deeply negative, reflecting a cash‑burning, pre‑revenue business. Overall, the stock sits at a critical juncture where technical weakness and financial fragility clash with a speculative upside narrative driven by its mineral assets and aggressive growth ambitions.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 6/10
Key Factors
- Bearish MACD and price below short‑term SMAs
- Proximity to support at $1.53
- High volatility and beta amplifying downside risk
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Pending lithium PEA and Fort Cady development milestones
- Large implied upside versus current price
- Continued cash burn and negative earnings
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Strategic borate and lithium assets in the U.S.
- Undervalued valuation relative to target price
- Potential for transformational upside if exploration succeeds
Key Metrics & Analysis
Financial Health
P/E Ratio-3.2
ROE-62.36%
ROA-34.57%
Debt/Equity0.17
P/B Ratio0.9
Op. Cash Flow$-20025000
Free Cash Flow$-13846125
Technical Analysis
TrendNeutral
RSI44.4
Support$1.53
Resistance$2.11
MA 20$1.79
MA 50$1.72
MA 200$3.00
MACDBearish
VolumeStable
Fear & Greed Index92.13
Valuation
Target Price$4.75
Upside/Downside193.21%
GradeUndervalued
TypeBlend
Risk Assessment
Beta1.95
Volatility122.13%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.